Sebastian Mathea - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sebastian Mathea

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

Journal of Medicinal Chemistry|July 2, 2025

Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.

ACS Chemical Biology|May 1, 2026

Discovery and Development of a Potent LIMK2 Isoform-Specific DegraderKamal Rayees Abdul Azeez, Hayuningbudi Saraswati, Thorsten Mosler, et al.

Cell|April 2, 2026

Rational discovery of therapeutic PAK1 allosteric activatorsYu He, James S H Bae, Elżbieta Nowak, et al.

Cell Chemical Biology|October 21, 2020

Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.

Pageof 6

Search research articles

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

Journal of Medicinal Chemistry|July 2, 2025

Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.

ACS Chemical Biology|May 1, 2026

Discovery and Development of a Potent LIMK2 Isoform-Specific DegraderKamal Rayees Abdul Azeez, Hayuningbudi Saraswati, Thorsten Mosler, et al.

Cell|April 2, 2026

Rational discovery of therapeutic PAK1 allosteric activatorsYu He, James S H Bae, Elżbieta Nowak, et al.

Cell Chemical Biology|October 21, 2020

Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.

Pageof 6